Egypt Devaluation Rages Again as New Currency Policy Moves Ahead
The Egyptian pound fell to yet another record low, a sign that authorities are pressing ahead with a shift to more flexible currency trading.
Bloomberg Business
Deal-Needy SPAC Sponsors Flock to Tiny Tie-Ups as Clock Ticks
Deal-hungry blank-check companies dashing to meet deadlines are eyeing smaller targets as the SPAC mania that led to dozens of multi-billion dollar mergers fizzles.
Hedge Fund Clients Seek Out Stock-Pickers After Tough 2022
Hedge fund clients profited most by investing in macro and multi-strategy hedge funds last year — and many of them are betting the same strategies will be winners again in 2023.
EasyJet Sees Travel Boom Continuing Despite Living Cost Crunch
EasyJet Plc expects the recovery in air travel to continue through 2023 despite consumers feeling the pinch from inflation, the latest sign of airline optimism following a stronger-than-expected Christmas travel season.
Viral ChatGPT Spurs Concerns About Propaganda and Hacking Risks
Ever since OpenAI’s viral chatbot was unveiled late last year, detractors have lined up to flag potential misuse of ChatGPT by email scammers, bots, stalkers and hackers.
Russia to Bring Soyuz Spacecraft Back to Earth Following Coolant Leak
Russia plans to bring its Soyuz spacecraft back to Earth without its original crew after the vehicle sprang a coolant leak while docked with the International Space Station.
Europe Debt Demand Is Already at Half a Trillion Dollars in 2023
Demand for Europe’s debt sales has topped half a trillion euros already this year as investors seek to put money to work in bonds offering some of the highest yields in years.
People Are Leaving Canada’s Biggest Cities Amid a Housing Crunch
Canada’s largest cities are getting bigger and more expensive, forcing hundreds of thousands of people to search for affordable housing elsewhere.
AbbVie Expects to Shake Off Risk From Humira’s US Competion
AbbVie Inc. doesn’t foresee an earnings slump in 2024, the first full year its blockbuster anti-inflammatory drug Humira faces competition from cheaper alternatives in the US.
Banks’ Revenue Bonanza Seen Under Threat From Looming US Recession
The market volatility and interest-rate hikes that gave US banks their biggest windfall last year may prove to be their biggest headache in 2023.
